Cristina Vazquez Guillamet

Medicine & Life Sciences

1. Septic Shock 100%
2. Infections 87%
3. Anti-Bacterial Agents 83%
4. Critical Illness 81%
5. Ventilator-Associated Pneumonia 69%
6. Lung 67%
7. Sepsis 63%
8. Intensive Care Units 59%
9. Methicillin-Resistant Staphylococcus aureus 58%
10. Transplant Recipients 56%
11. Mortality 53%
12. Artificial Respiration 37%
13. Gram-Negative Bacteria 34%
14. Acinetobacter 34%
15. Pneumonia 32%
16. Cohort Studies 30%
17. Lung Transplantation 30%
18. Decision Making 29%
19. Microbial Drug Resistance 29%
20. Thorax 29%
21. Healthcare-Associated Pneumonia 29%
22. Hospital Rapid Response Team 28%
23. B7-H1 Antigen 28%
24. Antimicrobial Stewardship 27%
25. Therapeutics 27%
26. Bacteremia 27%
27. Cefepime 26%
28. Coronavirus 26%
29. Clinical Decision Rules 26%
30. Skilled Nursing Facilities 25%
31. Candidemia 24%
32. Epidemiology 24%
33. Soft Tissue Infections 24%
34. Meropenem 24%
35. Tazobactam Drug Combination Piperacillin 23%
36. Terminal Care 23%
37. Gram-Positive Bacteria 23%
38. Pseudomonas 22%
39. Critical Care 22%
40. Numbers Needed To Treat 22%
41. Hospital Mortality 22%
42. Odds Ratio 22%
43. Confidence Intervals 21%
44. Immunocompromised Host 21%
45. Multiple Drug Resistance 20%
46. Bronchoalveolar Lavage 19%
47. Retrospective Studies 17%
48. Vancomycin-Resistant Enterococci 17%
49. Smoke 17%
50. Tobacco Products 17%